3′RNA Sequencing Accurately Classifies Formalin-Fixed Paraffin-Embedded Uterine Leiomyomas
Authors:
Open Access
Abstract
Uterine leiomyomas are benign smooth muscle tumors occurring in 70% of women of reproductive age. The majority of leiomyomas harbor one of three well-established genetic changes: a hotspot mutation in MED12, overexpression of HMGA2, or biallelic loss of FH. The majority of studies have classified leiomyomas by complex and costly methods, such as whole-genome sequencing, or by combining multiple traditional methods, such as immunohistochemistry and Sanger sequencing. The type of specimens and the amount of resources available often determine the choice. A more universal, cost-effective, and scalable method for classifying leiomyomas is needed. The aim of this study was to evaluate whether RNA sequencing can accurately classify formalin-fixed paraffin-embedded (FFPE) leiomyomas. We performed 3′RNA sequencing with 44 leiomyoma and 5 myometrium FFPE samples, revealing that the samples clustered according to the mutation status of MED12, HMGA2, and FH. Furthermore, we confirmed each subtype in a publicly available fresh frozen dataset. These results indicate that a targeted 3′RNA sequencing panel could serve as a cost-effective and robust tool for stratifying both fresh frozen and FFPE leiomyomas. This study also highlights 3′RNA sequencing as a promising method for studying the abundance of unexploited tissue material that is routinely stored in hospital archives.Keywords
Funding Information
- Research Council of Finland (307773)
- Sigrid Juséliuksen Säätiö (-)
- Syöpäsäätiö (-)
- iCAN Digital Precision Cancer Medicine Flagship (-)
This publication has 39 references indexed in Scilit:
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samplesNature Biotechnology, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Medical Treatment of Uterine LeiomyomaReproductive Sciences, 2012
- MED12 mutations in uterine fibroids—their relationship to cytogenetic subgroupsInternational Journal of Cancer, 2012
- Chipster: user-friendly analysis software for microarray and other high-throughput dataBMC Genomics, 2011
- Aberrant succination of proteins in fumarate hydratase‐deficient mice and HLRCC patients is a robust biomarker of mutation statusThe Journal of Pathology, 2011
- Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristicsFamilial Cancer, 2011
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Determinants of RNA Quality from FFPE SamplesPLOS ONE, 2007
- Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyomaCancer Genetics and Cytogenetics, 2005